About Chris Chapman
Form D filings for Telomir Pharmaceuticals from 2023 to 2024 list Chris Chapman as CEO & Chairman.
Chris Chapman reports to the SEC as a director or officer of 4 public companies, including Mira Pharmaceuticals (MIRA), Q/c Technologies (QCLS) and Rock Creek Pharmaceuticals (RCPI).
Chris Chapman first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Chris Chapman in the role, so the role may have started earlier or lasted longer.
MI
Mira Pharmaceuticals, Inc.
Executive Chairman
2023 · Public company (MIRA)
QI
Q/c Technologies, Inc.
President, Chief Med. Officer and director
2021 – 2023 · Public company (QCLS)
RI
Rock Creek Pharmaceuticals, Inc.
President and director
2006 – 2013 · Public company (RCPI)
Key Colleagues at Startups
The people Chris Chapman works with at each company, as listed on that company's latest Form D.
Telomir Pharmaceuticals, Inc. · Form D, Apr 3, 2023
TT
Tuck Talhia
Director
CE
Craig Eagle
Director
DV
David Vorhoff
Director
JM
James McNulty
Treasurer, Chief Financial Officer and Secretary
HM
Hugh McColl
Director
JU
Jude Uzonwanne
Director